利巴韦林联合地塞米松治疗贝尔麻痹疗效分析  

Application of Ribovirin and Dexamethasone to the therapy for Bell paralysis

作　　者：刘汉伟[1] 梁军[2] 朱燕华[2] 刘金刚[2] 

机构地区：[1]中山大学附属第五医院神经内科,广东519000 [2]中山大学附属第五医院口腔颌面外科,广东519000

出　　处：《中国实用口腔科杂志》2011年第5期299-300,共2页Chinese Journal of Practical Stomatology

摘　　要：目的研究利巴韦林和地塞米松在贝尔麻痹治疗中的应用效果。方法选取2002年8月至2010年10月中山大学附属第五医院神经内科和口腔科收治的贝尔麻痹患者60例,按就诊顺序随机分为A、B两组,每组30例。A组给予利巴韦林和地塞米松联合治疗,B组仅给予地塞米松治疗。两组患者治疗前、后均以Portmann简易评分法评分,并进行比较分析。结果治疗前,60例患者疗效评分均<9分。治疗后,A组满意率为80.33%,明显高于B组(60.00%),且差异有统计学意义(P<0.05)。结论应用利巴韦林联合地塞米松治疗贝尔麻痹效果良好,值得临床推广。Objective To investigate the effect of Ribovirin and Dexamethasone in the treatment for Bell paralysis.Methods A total of 60 patients with Bell paralysis were randomly divided into two groups：A and B,each with 30 patients.Treatment group（A） was treated by Ribovirin and Dexamethasone;control group（B） was treated by Dexamethasone only.Results The 30 cases of Bell paralysis by Ribovirin and Dexamethasone therapy recovered better;therapeutic efficacy was better in treatment group than in control group,P〈0.05,there being statistical significance in the two groups.Conclusion The effect of Ribovirin and Dexamethasone in the treatment for Bell paralysis is good,whith can be generalized.

关 键 词：贝尔麻痹 利巴韦林 地塞米松 

分 类 号：R78[医药卫生—口腔医学]